244 related articles for article (PubMed ID: 11990780)
21. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
22. Astrocyte-endothelial interactions and blood-brain barrier permeability.
Abbott NJ
J Anat; 2002 Jun; 200(6):629-38. PubMed ID: 12162730
[TBL] [Abstract][Full Text] [Related]
23. Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.
Sajja RK; Cucullo L
Neurosci Lett; 2015 Jun; 598():59-65. PubMed ID: 25982326
[TBL] [Abstract][Full Text] [Related]
24. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity.
Potschka H; Fedrowitz M; Löscher W
J Pharmacol Exp Ther; 2003 Jul; 306(1):124-31. PubMed ID: 12663688
[TBL] [Abstract][Full Text] [Related]
26. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.
Miller DS
Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266
[TBL] [Abstract][Full Text] [Related]
27. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
[TBL] [Abstract][Full Text] [Related]
28. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
Löscher W; Potschka H
J Pharmacol Exp Ther; 2002 Apr; 301(1):7-14. PubMed ID: 11907151
[TBL] [Abstract][Full Text] [Related]
29. Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.
Lazarowski A; Ramos AJ; García-Rivello H; Brusco A; Girardi E
Cell Mol Neurobiol; 2004 Feb; 24(1):77-85. PubMed ID: 15049512
[TBL] [Abstract][Full Text] [Related]
30. Structural, Molecular, and Functional Alterations of the Blood-Brain Barrier during Epileptogenesis and Epilepsy: A Cause, Consequence, or Both?
Löscher W; Friedman A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963328
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
[TBL] [Abstract][Full Text] [Related]
32. Vascular colocalization of P-glycoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies.
Sisodiya SM; Martinian L; Scheffer GL; van der Valk P; Scheper RJ; Harding BN; Thom M
Neuropathol Appl Neurobiol; 2006 Feb; 32(1):51-63. PubMed ID: 16409553
[TBL] [Abstract][Full Text] [Related]
33. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
Kwan P; Brodie MJ
Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503
[TBL] [Abstract][Full Text] [Related]
34. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
Löscher W; Potschka H
NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
[TBL] [Abstract][Full Text] [Related]
35. P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.
Potschka H; Fedrowitz M; Löscher W
Neurosci Lett; 2002 Jul; 327(3):173-6. PubMed ID: 12113905
[TBL] [Abstract][Full Text] [Related]
36. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
[TBL] [Abstract][Full Text] [Related]
37. Drug transporters in the epileptic brain.
Löscher W
Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
[TBL] [Abstract][Full Text] [Related]
38. Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.
Wanek T; Mairinger S; Langer O
J Labelled Comp Radiopharm; 2013; 56(3-4):68-77. PubMed ID: 24285312
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid can be used as a surrogate to assess brain exposures of breast cancer resistance protein and P-glycoprotein substrates.
Xiao G; Black C; Hetu G; Sands E; Wang J; Caputo R; Rohde E; Gan LS
Drug Metab Dispos; 2012 Apr; 40(4):779-87. PubMed ID: 22266779
[TBL] [Abstract][Full Text] [Related]
40. ABC Transporters and Drug Resistance in Patients with Epilepsy.
Feldmann M; Koepp M
Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]